Vista.ai
Generated 5/4/2026
Executive Summary
Vista.ai is a digital health company that has developed an FDA-cleared AI platform to automate MRI acquisition, initially focusing on cardiac MRI. The platform reduces scan times and enables less experienced technologists to perform complex scans, addressing the shortage of skilled personnel and inconsistent imaging quality. By standardizing and streamlining the imaging process, Vista.ai aims to make high-quality, gold-standard MRI accessible across diverse healthcare settings, improving patient outcomes and operational efficiency. The company, based in San Francisco and founded in 2018, has demonstrated strong potential to disrupt the radiology market with its software-first approach, though it remains private and early-stage with limited public traction.
Upcoming Catalysts (preview)
- Q4 2026Expansion to additional MRI modalities (e.g., neuro, abdominal)60% success
- Q3 2026Strategic partnership with major imaging equipment manufacturer50% success
- Q2 2026Publication of clinical trial demonstrating improved outcomes or cost savings70% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)